CSL Limited (ASX:CSL) has increased 0.6% to trade at AUD282.37 vs. the S&P/ASX 200 Health Care index which strengthened 115.1 points (or 0.3%) to 41,686.4. Representing a weighting of about 53.1% of the index, the stock accounted for the gain. Trading volume has been 57% of average so far today.
SECTION 1: Technical indicatorsBullish:
The present value of AUD1,000 invested one year ago is AUD1,311 [vs AUD891 for the All Ordinaries Index], including a capital gain of AUD296 and dividend reinvested of AUD14. The total return to shareholders for 1 year is 31.1%.
Fundamental measures by comparison with the sector average [in brackets] indicate:
Dividend yield of 1% [0.8%]
Return on Equity 36.5% [16.9%]
Return on Assets 15.6% [8.1%]
Return on Capital Employed 23.1% [13.3%]
Total Liabilities/EBITDA of 3 is comfortably below the Joseph Piotroski benchmark of <5.
The stock is at a discount of 17.2% to the 12-month high of AUD341.18 on 20 Feb, 2020. It is also at a premium of 32.6% to the 12-month low of AUD212.93 on 06 Aug, 2019.
The negative 1.96 MACD (Moving Average Convergence Divergence) indicator suggests a bearish signal (12-day minus 26-day Exponential Moving Averages). Both the 12-day and the 26-day EMA are falling - another bearish signal. In the past week, the stock's MACD has been negative every day, a reinforcing bearish signal.
The price sank 5.1% in the last week and decreased 1.2% in the last month.
SECTION 2: Ranking
|Description||Value||Rank In Market|
|MCap USD billion||88.8||In Top 1%|
|Today's Volatility %||1.4||In Top Quartile|
|52-week Range (in AUD)||212.9-341.2|
|1-month Range (in AUD)||278.8-298.0|
CSL Limited (AU:CSL; ASX:CSL; AX:CSL)